Biomedical Engineering Reference
In-Depth Information
polypeptide1B1(OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/
multidrug resistance 1, and OATP1B1/breast cancer resistance protein. J Pharmacol Exp
Ther 314:1059-1067.
60. Cui Y, K onig J, Keppler D. 2001. Vectorial transport by double-transfected cells express-
ing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol
Pharmacol 60:934-943.
61. Letschert K, Komatsu M, Hummel-Eisenbeiss J, Keppler D. 2005. Vectorial transport of
the peptide CCK-8 by double-transfected MDCKII cells stably expressing the organic
anion transporter OATP1B3 (OATP8) and the export pump ABCC2. J Pharmacol Exp
Ther 313:549-556.
62. Kopplow K, Letschert K, K onig J, Walter B, Keppler D. 2005. Human hepatobiliary trans-
port of organic anions analyzed by quadruple-transfected cells. Mol Pharmacol 68:1031-
1038.
63. Hirouchi M, Suzuki H, Sugiyama Y. 2005. Treatment of hyperbilirubinemia in Eisai
hyperbilirubinemic rat by transfection human MRP2/ABCC2 gene. Pharm Res 22:661-
666.
64. Miller RE, Guengerich FP. 1983. Metabolism of trichloroethylene in isolated hepatocytes,
microsomes, and reconstituted enzyme systems containing cytochrome P-450. Cancer
Res 43:1145-1152.
65. Yu A, Dong H, Lang D, Haining RL. 2001. Characterization of detromethorphan O- and
N-demethylation catalyzed by highly purified recombinant human CYP2D6. Drug Metab
Dispos 29:1362-1365.
66. Gonzalez FJ. 2003. Role of gene knockout and transgenic mice in the study of xenobiotic
metabolism. Drug Metab Rev 35:319-335.
67. Gonzalez FJ. 2004. Cytochrome P450 humanised mice. Human Genom 4:300-306.
68. Gonzalez FJ, Yu AM. 2006. Cytochrome P450 and xenobiotic receptor humanized mice.
Annu Rev Pharmacol Toxicol 46:41-64.
69. Mei Q, Tang C, Lin Y, Rushmore TH, Shou M. 2002. Inhibition kinetics of monoclonal
antibodies against cytochromes P450. Drug Metab Dispos 30:701-708.
70. Kobyashi K, Urashima K, Shimada N, Chiba K. 2002. Substrate specificity for rat cy-
tochrome P450 (CYP) isoforms: screening with cDNA-expressed systems in the rat.
Biochem Pharmacol 63:889-896.
71. Lin JH, Wong BK. 2002. Complexities of glucuronidation affecting in vitro-in vivo
extrapolation. Curr Drug Metab 3:623-646.
72. Miners JO, Knights KM, Houston JB, Mackenzie PI. 2006. In vitro-in vivo correlation
for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and
promises. Biochem Pharmacol 71:1531-1539.
73. Liu X, Chism P, LeCluyse EL, Brouwer KR, Brouwer KL. 1999. Correlation of biliary
excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metab Dispos
27:637-644.
74. Hoffmaster KA, Turncliff RZ, LeCluyse EL, Kim RB, Meier PJ, Brouwer KL. 2004. P-
glycoprotein expression, localization, and function in sandwich-cultured primary rat and
human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide.
Pharm Res 21:1294-1302.
75. Hoffmaster KA, Zamek-Gliszczynski MJ, Pollack GM, Brouwer KL. 2004. Hepatobil-
iary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin
Search WWH ::
Custom Search